Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 17, 2020

SELL
$78.31 - $95.34 $1,566 - $1,906
-20 Closed
0 $0
Q1 2019

Apr 04, 2019

SELL
$107.15 - $126.84 $2,143 - $2,536
-20 Reduced 50.0%
20 $2,000
Q4 2018

Jan 25, 2019

BUY
$101.4 - $128.73 $4,056 - $5,149
40 New
40 $4,000

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.5B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Orrstown Financial Services Inc Portfolio

Follow Orrstown Financial Services Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orrstown Financial Services Inc, based on Form 13F filings with the SEC.

News

Stay updated on Orrstown Financial Services Inc with notifications on news.